CLINICAL_TRIALS
trial_result
· 2007-10-22
Clinical Trial Update: Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) [Phase 1]
Summary
Phase 1 pilot studies are exploring novel therapies for resistant focal segmental glomerulosclerosis (FSGS); the trials have completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Northwell Health | Conditions: Focal Glomerulosclerosis | Phase 1 | Status: COMPLETED